文献速递血栓与止血

全外显子组测序在静脉血栓栓塞症患者评估中的应用

Whole-exome sequencing in evaluation of patients with venous thromboembolism.
PubMed 文献 · Blood Adv · 2017-06-29

该研究对64例静脉血栓栓塞症(VTE)患者行全外显子组测序(WES),并分析自建的55基因扩展易栓症 panel;在39/64例(60.9%)患者中检出可能致病或意义未明的基因变异,而237例无VTE对照中仅6例(2.5%)检出(P < .0001)。

要点

  • WES联合55基因扩展易栓症 panel 在60.9%(39/64)的VTE患者中检出可能致病或意义未明变异。
  • 无VTE对照中仅2.5%(6/237)检出变异,组间差异 P < .0001。
  • 常规临床实验室易栓症检测仅在25.9%(14/54)的患者中确定遗传性易栓症。

核心结论

  • WES与扩展易栓症检测是有前景的工具,有助于增进对VTE发病机制的理解并识别遗传性易栓症。

研究设计与样本

  • 对64例VTE患者行全外显子组测序(WES),分析聚焦于自建的55基因扩展易栓症 panel,并与237例无VTE对照比较。

主要发现

  • 扩展易栓症 panel 在39/64例(60.9%)VTE患者中检出可能致病或意义未明变异,而无VTE对照为6/237例(2.5%)(P < .0001)。
  • 常规临床实验室易栓症检测仅在14/54例(25.9%)VTE患者中确定遗传性易栓症。
  • 多数WES变异或据文献既往报道与血栓形成相关,或据本研究蛋白建模预测影响蛋白结构。
  • 变异见于主要易栓症基因、多种SERPIN基因及在凝血或纤溶中已确立或潜在作用的其他基因的高度保守区域。
  • 10例患者(15.6%)携带超过1个变异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Genetics play a significant role in venous thromboembolism (VTE), yet current clinical laboratory-based testing identifies a known heritable thrombophilia (factor V Leiden, prothrombin gene mutation G20210A, or a deficiency of protein C, protein S, or antithrombin) in only a minority of VTE patients. We hypothesized that a substantial number of VTE patients could have lesser-known thrombophilia mutations. To test this hypothesis, we performed whole-exome sequencing (WES) in 64 patients with VTE, focusing our analysis on a novel 55-gene extended thrombophilia panel that we compiled. Our extended thrombophilia panel identified a probable disease-causing genetic variant or variant of unknown significance in 39 of 64 study patients (60.9%), compared with 6 of 237 control patients without VTE (2.5%) (P < .0001). Clinical laboratory-based thrombophilia testing identified a heritable thrombophilia in only 14 of 54 study patients (25.9%). The majority of WES variants were either associated with thrombosis based on prior reports in the literature or predicted to affect protein structure based on protein modeling performed as part of this study. Variants were found in major thrombophilia genes, various SERPIN genes, and highly conserved areas of other genes with established or potential roles in coagulation or fibrinolysis. Ten patients (15.6%) had >1 variant. Sanger sequencing performed in family members of 4 study patients with and without VTE showed generally concordant results with thrombotic history. WES and extended thrombophilia testing are promising tools for improving our understanding of VTE pathogenesis and identifying inherited thrombophilias.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Lee EJ, Dykas DJ, Leavitt AD, et al. Whole-exome sequencing in evaluation of patients with venous thromboembolism. Blood Adv. 2017. PMID: 29296762. doi:10.1182/bloodadvances.2017005249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。